Search
Sign Up
Home
Team
Pipeline
Back
Sr89/Metastron
QBM-001
Uttroside-B
MAN-01
Investors
Back
Presentations
Stock Info
Filings
Media
News
Back
News 2025
News 2024
News 2023
News 2022
News 2021
News 2020
News 2019
News 2018
News 2017
News 2016
Contact
Video & Social Media
Watch us in interviews. Follow us.
News 2018
List of articles in category News 2018
Title
Created Date
Q BioMed Announces Strategic Partnership with SRI International for Formulation and Preclinical Development of QBM-001 for Pediatric Nonverbal Disorder in Autistic Children
Dec
12, 2018
Q BioMed Inc Announces Acquisition of Cancer Pain Drug Metastron™ from GE Healthcare
Nov
28, 2018
Q BioMed Takes the Stage in the Expanded Access Debate at European Early and Managed Access Program Conference
Oct
26, 2018
Q BioMed Provides Important Update on QBM001 Developmental Drug Targeting a Non-Verbal and Minimally Verbal Patient Subset on the Autism Spectrum
Oct
09, 2018
Q Biomed Inc. Announces Entry Into Definitive Funding Agreement for $4,000,000
Sep
24, 2018
Q Biomed Inc. Announces Dr. Rajendra Apte Joins Advisory Board
Sep
17, 2018
Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain
Aug
20, 2018
Q Biomed Inc. Extends its Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma and Initiates a Clinical Study
Jul
25, 2018
Q BioMed Inc Places 2nd in Company Category for Autism Speaks Walk Fundraiser
Jun
01, 2018
Q Biomed Inc. to Present at the Microcap Conference Taking Place April 9-10 at the Essex House in New York City
Apr
05, 2018
Q Biomed Inc. Announces FDA Filing for Approval of a New Manufacturing Facility for Non-Opioid Strontium Chloride SR89 Injection USP for Relief of Cancer Bone Pain
Mar
16, 2018
Q BioMed Inc. to Present at 30th Annual Roth Conference, Taking Place March 11-14, 2018, in Dana Point, CA
Mar
09, 2018
Washington University researchers evaluate biomarker for glaucoma
Feb
28, 2018
Q BioMed Adds Big Pharma Executive to Board of Directors
Feb
13, 2018
Q Biomed Inc. Signs Exclusive Option Agreement With Washington University in St. Louis for a Novel Companion Biomarker for Monitoring Glaucoma
Feb
08, 2018
Q Biomed Inc. Closes $5.48 Million Public Offering
Feb
01, 2018
Q BioMed Inc. Prices $5.5 Million Public Offering
Jan
30, 2018
Q Biomed Inc. to Present at Biotech Showcase(™) 2018
Jan
03, 2018